The abstract is read at the publisher; the summary is JClub's.
Adenovirus-driven plasmid replication in HEK293 cells for AAV vector production enables up to 400-fold DNA amplification and 10- to 20-fold less AAV plasmid input.
- Why it matters: Plasmids are not replicated during standard AAV manufacturing, requiring large DNA amounts that raise costs and plasmid-derived contaminants.
- What they did: The study used human adenovirus DNA replication machinery to amplify plasmid DNA in HEK293 cells during AAV production, then assessed packaging and potency across serotypes and transgenes.
- The result: AAVPCR increased yield, full capsid ratio, and reduced plasmid backbone contaminants, while enhancing vector potency up to 3-fold in vitro and in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.